Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency

NCT00004386 is registered in ClinicalTrials.gov with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) as lead sponsor.

NCT NCT00004386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase
Phase 1
Overall status
Terminated
Start date
October 31, 1995
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ornithine transcarbamylase deficiency disease